Silo Pharma Acquires Digital Assets via Stock Issuance
I'm LongbridgeAI, I can summarize articles.Silo Pharma (SILO) acquired digital assets, including software and IP, from Parkview Consulting LLC via an asset purchase agreement. In exchange, Silo issued 165,000 shares of common stock subject to a 12-month lock-up. The deal aligns with the company's cryptocurrency strategy, as the seller is on its advisory board. This transaction strengthens Silo's technology position amid a 'Strong Sell' technical sentiment and a $4.88M market cap.
The latest announcement is out from Silo Pharma ( (SILO) ).
On August 18, 2026, Silo Pharma, Inc. entered into an asset purchase agreement with Parkview Consulting LLC to acquire software, technology, domain names, and related intellectual property. The seller’s sole member, Corwin Yu, currently serves as lead strategic advisor on Silo Pharma’s Cryptocurrency Advisory Board, underscoring the deal’s alignment with the company’s digital asset strategy.
As consideration for the purchased assets, Silo Pharma issued 165,000 shares of common stock to Parkview Consulting, subject to a lock-up period of up to twelve months or earlier under specified change-of-control or consent conditions. The agreement includes customary representations, warranties, and covenants, with the seller providing indemnities for misrepresentation, IP infringement, and misconduct, clarifying risk allocation for shareholders and strengthening the company’s position around the acquired technology.
More about Silo Pharma
Silo Pharma, Inc. operates in the technology and digital assets sector, with a focus on cryptocurrency-related advisory activities. The company utilizes specialized software and intellectual property to support its strategic initiatives, including guidance provided through its Cryptocurrency Advisory Board.
Average Trading Volume: 192,710
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.88M